Fri 3 Apr 2020 CEO statement on coronavirus | COVID-19 The COVID-19 pandemic is having an unprecedented impact on our world, and clearly our first thoughts are with those people affected by this virus. ...
Thu 28 Jan 2021 DORC announces Health Canada approval of TissueBlue™ for Staining of the ILM During Vitreoretinal Surgery – the first Health Canada approved product for this indication. | Press Release DORC announces Health Canada approval of TissueBlue™ for Staining of the ILM During Vitreoretinal Surgery – the first Health Canada ap...